Gretchen Frantz

Medicine · Health Sciences

37h-index8.9kcitations71works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(14), Monoclonal and Polyclonal Antibodies Research(12), Angiogenesis and VEGF in Cancer(11), FOXO transcription factor regulation(7), Cancer, Hypoxia, and Metabolism(6)

Publications71 total

Data from Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma
2023Open Access
Supplementary Figure 1 from Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma
2023Open Access
Supplementary Figure 1 from Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma
2023Open Access
Data from Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma
2023Open Access
Supplementary Legends from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Supplementary Table 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Data from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Data from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Supplementary Figures 1-6 from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Data from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Data from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Supplementary Legends from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Supplementary Figures 1-6 from Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2023Open Access
Supplementary Figure Legend from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Supplementary Figure Legend from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Supplementary Table 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Supplementary Figure 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Supplementary Figure 1 from Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
2023Open Access
Clinical, operative, and pathologic outcomes following neoadjuvant therapy versus upfront surgery for ampullary, duodenal and distal bile duct adenocarcinoma
HPB·2021· 1 citedOpen Access
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
The Lancet·2019· 989 cited
page 1 of 4Next →

Frequent Co-authors

Kenneth J. Hillan(13), Franklin Peale(11), Hartmut Koeppen(8), Napoleone Ferrara(8), Frédéric J. de Sauvage(8), Dorothy French(6), Jennifer LeCouter(5), Zemin Zhang(5), Adrian M. Jubb(5), Allan J. Tobin(5), Patrick J. Dowd(4), Austin Gurney(4), Joe Kowalski(4), Lisa Dillard‐Telm(4), Richard A.D. Carano(4), Wei‐Qiang Gao(4), Vishva M. Dixit(3), Jessica Foster(3), Linda Rangell(3), Craig Crowley(3)